Explore

SARS-CoV-2 Infection Linked to Autoimmune Activation Similar to Lupus

SARS-CoV-2 Infection Linked to Autoimmune Activation Similar to Lupus

Recent scientific studies indicate that infection with SARS-CoV-2, the virus causing COVID-19, can trigger an immune response akin to those observed in established autoimmune diseases. This activation may explain why some individuals develop autoimmune complications following COVID-19. Research published in 'Immunity' specifically identified atypical memory B cells, particularly DN2 B cells, as key players in producing autoantibodies in COVID-19 patients. These cells have also been implicated in other autoimmune conditions, such as lupus. The findings suggest that COVID-19 might activate the same immune pathways that lead to lupus, potentially initiating or exacerbating autoimmune conditions in susceptible individuals. This discovery sheds light on the complex post-viral syndromes experienced by some patients and provides a potential biological mechanism for these long-term health issues. The activation of these specific B cells and their role in autoantibody production points to a direct link between the ...

Sarasota Herald-Tribune

Florida leprosy cases rise to 22, ancient disease spreading

Florida leprosy cases rise to 22, ancient disease spreading

Three new leprosy cases were confirmed in Florida, keeping the state among the nation's leading hotspots.

Representative Don Bacon Praises University of Nebraska Medical Center's Role in Biodefense and Public Health

Representative Don Bacon Praises University of Nebraska Medical Center's Role in Biodefense and Public Health

Representative Don Bacon (R-Neb.) lauded the University of Nebraska Medical Center (UNMC) as the "gold standard" for its effective partnerships with the federal government and the military, particularly in biodefense and public health. His remarks came during the groundbreaking ceremony for a new Infectious Diseases Air Transport training facility at UNMC. This $17.4 million project, set to open in early 2028, will be the first of its kind in the U.S., housing biocontainment transport modules and an aircraft fuselage for advanced training of U.S. Air Force members from the Center for Sustainment of Trauma and Readiness Skills (C-STARS). Bacon highlighted UNMC's critical roles in quarantining American cruise ship passengers exposed to hantavirus, its response to the COVID-19 pandemic, and its aid during multiple Ebola outbreaks, including treating three Ebola patients in 2014. He emphasized UNMC's capability in handling challenging health security tasks, stating, "You showed the world what you can do with a...

New Dried-Blood Method Accelerates Zika and Hepatitis C Diagnosis, Enhancing Global Accessibility

New Dried-Blood Method Accelerates Zika and Hepatitis C Diagnosis, Enhancing Global Accessibility

A new diagnostic method has been developed that enables the direct detection of hepatitis C and Zika virus from dried whole blood samples. This innovative approach bypasses the complex and equipment-intensive sample preparation steps typically required for conventional laboratory diagnostics, such as centrifugation, extraction, and purification. According to Rashid Bashir, PhD, professor of bioengineering at the University of Illinois Urbana-Champaign, the method captures and stabilizes target RNA molecules by drying the blood sample. RNA amplification can then be performed directly on the sample using dried primers and reagents, eliminating the need for cold-chain logistics. The entire diagnostic workflow only requires a simple heater for preparation and amplification, along with a compact, low-cost fluorescence reader for signal detection, maintaining accuracy comparable to standard-of-care methods while significantly improving accessibility and availability.

Malawi Successfully Controls Severe Cholera Outbreak Through Targeted Interventions and US Funding

Malawi Successfully Controls Severe Cholera Outbreak Through Targeted Interventions and US Funding

Malawi has successfully brought a severe cholera outbreak under control in a district that previously accounted for approximately 47% of the nation's total cholera burden. Dr. Endale Tilahun, Chief of Party in Malawi for Project HOPE Namibia, reported that targeted interventions, supported by limited US government funding, led to several weeks without any confirmed or suspected cholera cases. These interventions included the provision of Water, Sanitation, and Hygiene (WASH) supplies, extensive community awareness campaigns, and improved access to safe water. Dr. Tilahun described the initiative as 'high impact,' noting that the district had not experienced a single cholera case for the past 5 to 9 weeks. This achievement highlights the effectiveness of focused public health strategies even with constrained resources.

Physicians Advise Public on West Nile Virus Prevention and Symptom Recognition Amid Peak Season

Physicians Advise Public on West Nile Virus Prevention and Symptom Recognition Amid Peak Season

Physicians are urging the public to take precautions against West Nile virus, a mosquito-borne disease that typically peaks in the U.S. during summer and fall, particularly in August and September. The virus is spread through the bite of infected mosquitoes, primarily Culex species, which acquire the virus from birds. While approximately 80% of infected individuals remain asymptomatic, others may experience symptoms such as fever, headache, body aches, fatigue, rash, nausea, or vomiting. A small percentage, about 1%, develop neuroinvasive disease, leading to severe conditions like encephalitis (brain inflammation) or meningitis (inflammation of the tissues surrounding the brain), which can result in lasting health problems or even death. Dr. Erica Kaufman West, an infectious diseases physician, and Dr. Chad C. Braden, a family physician, emphasize that there is no vaccine or specific medication to prevent or cure West Nile virus in humans. Therefore, prevention through avoiding mosquito bites is crucial.

Lindsay Clancy Case Highlights Urgent Reality of Postpartum Psychosis and Gaps in Care

Lindsay Clancy Case Highlights Urgent Reality of Postpartum Psychosis and Gaps in Care

The case of Lindsay Clancy, a 36-year-old former nurse who pleaded not guilty to the deaths of her three children in January 2023, has brought significant attention to postpartum psychosis. Prosecutors allege Clancy planned the killings, while her defense argues she was experiencing severe postpartum psychosis, including delusions and hallucinations. This ongoing case has globally highlighted the devastating reality of this severe mental health condition and the existing gaps in its diagnosis and treatment. Experts, such as Crystal Schiller, a clinical psychologist at the University of North Carolina at Chapel Hill Center for Women’s Mood Disorders, emphasize the critical need for increased awareness to ensure women experiencing severe symptoms receive timely help. Dr. Soudabeh Givrad, an associate professor of psychiatry and behavioral sciences at Stanford Medicine, notes that symptoms can begin within two weeks postpartum, affecting one to two women per 1,000 births, and is considered a psychiatric emerg...

US phases out $45M annual support for Namibia HIV program

US phases out $45M annual support for Namibia HIV program

The United States plans to phase out financial support for Namibia's HIV response programs

Representative Don Bacon Co-Sponsors PKD Cures Act to Advance Polycystic Kidney Disease Research

Representative Don Bacon Co-Sponsors PKD Cures Act to Advance Polycystic Kidney Disease Research

Representative Don Bacon (R-Neb.) has co-sponsored the PKD Cures Act, bipartisan legislation introduced in the U.S. House of Representatives aimed at advancing research for polycystic kidney disease (PKD). This bill, also co-sponsored by Reps. Debbie Wasserman Schultz (D-Fla.), Carol Miller (R-W.Va.), and Emanuel Cleaver (D-Mo.), marks the first federal legislation exclusively dedicated to PKD research. The PKD Cures Act seeks to expand research initiatives at the National Institutes of Health, accelerate clinical trials and the development of new therapies, establish research priorities through expert and patient input, and create a long-term federal research roadmap. The PKD Foundation is actively advocating for the bill's passage, coinciding with PKD Awareness Day, to capitalize on the current rapid pace of PKD research and ensure that scientific discoveries translate into patient treatments more quickly. Approximately 500,000 people in the U.S. live with PKD, a genetic disorder that can lead to kidney ...

Doctors Without Borders Calls for Inclusion of Children in Ebola Treatment Research

Doctors Without Borders Calls for Inclusion of Children in Ebola Treatment Research

Doctors Without Borders (Médecins Sans Frontières - MSF) has issued a call for the urgent inclusion of children in research and development for Ebola treatment and prevention. Specifically, MSF advocates for timely access to pediatric formulations of oral post-exposure prophylaxis (PEP) in ongoing trials, including the oral antiviral pill obeldesivir manufactured by US-based Gilead Sciences. The current EBO-PEP study, which commenced on July 14, is evaluating obeldesivir for preventing infection after high-risk exposure to the Bundibugyo virus, a cause of Ebola disease. While a planned protocol amendment is expected to include children over 44 pounds, those under 44 pounds (approximately age 6 or younger) remain excluded due to the lack of an available pediatric formulation and insufficient data on tablet crushing or dissolution. Dr. Neal Russell, MSF pediatric advisor, emphasized that children are at a disproportionately high risk of dying if infected with Ebola in the current outbreak in the Democratic R...

Dr. Richard J. Hatchett Advocates for Reimagined Vaccine Development and Pandemic Preparedness

Dr. Richard J. Hatchett Advocates for Reimagined Vaccine Development and Pandemic Preparedness

Dr. Richard J. Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI) and recipient of the 2026 NFID Jimmy and Rosalynn Carter Humanitarian Award, emphasized the need to reimagine vaccine development and pandemic preparedness. In a discussion with the National Foundation for Infectious Diseases (NFID), Dr. Hatchett highlighted the '100 Days Mission,' an initiative aiming to compress vaccine development timelines to within 100 days of identifying a new pathogen. He stressed that epidemic and pandemic diseases are not 'black swans' but rather a product of the environment and world humans have created, viewing them as a fundamental security problem. Dr. Hatchett also underscored the critical importance of robust disease surveillance capabilities, noting that underinvestment in these areas can lead to delayed detection and larger outbreaks, as seen with the Bundibugyo virus outbreak in the Democratic Republic of the Congo. He advocates for systemic institutional commitments and sustained p...